|
Koninklijke Philips N.V. (PHG) Évaluation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Koninklijke Philips N.V. (PHG) Bundle
Conçu pour la précision, notre calculatrice (PHG) DCF vous permet d'évaluer l'évaluation de Koninklijke Philips N.V. à l'aide de données financières du monde réel, tout en offrant une flexibilité complète pour modifier tous les paramètres essentiels pour des projections améliorées.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22,209.0 | 19,504.3 | 20,267.2 | 20,656.0 | 20,487.7 | 20,120.8 | 19,760.5 | 19,406.6 | 19,059.1 | 18,717.8 |
| Revenue Growth, % | 0 | -12.18 | 3.91 | 1.92 | -0.81457 | -1.79 | -1.79 | -1.79 | -1.79 | -1.79 |
| EBITDA | 3,128.7 | 2,269.2 | 130.7 | 1,183.5 | 2,181.7 | 1,720.1 | 1,689.3 | 1,659.1 | 1,629.4 | 1,600.2 |
| EBITDA, % | 14.09 | 11.63 | 0.64509 | 5.73 | 10.65 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
| Depreciation | 1,662.1 | 1,504.1 | 1,821.3 | 1,433.6 | 1,579.1 | 1,562.6 | 1,534.6 | 1,507.1 | 1,480.1 | 1,453.6 |
| Depreciation, % | 7.48 | 7.71 | 8.99 | 6.94 | 7.71 | 7.77 | 7.77 | 7.77 | 7.77 | 7.77 |
| EBIT | 1,466.6 | 765.1 | -1,690.5 | -250.1 | 602.5 | 157.6 | 154.7 | 152.0 | 149.2 | 146.6 |
| EBIT, % | 6.6 | 3.92 | -8.34 | -1.21 | 2.94 | 0.78305 | 0.78305 | 0.78305 | 0.78305 | 0.78305 |
| Total Cash | 3,667.6 | 2,620.5 | 1,344.9 | 2,128.2 | 2,731.9 | 2,423.5 | 2,380.1 | 2,337.5 | 2,295.6 | 2,254.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5,185.3 | 4,874.9 | 4,688.5 | 4,832.9 | 4,678.3 | 4,736.7 | 4,651.9 | 4,568.6 | 4,486.8 | 4,406.4 |
| Account Receivables, % | 23.35 | 24.99 | 23.13 | 23.4 | 22.83 | 23.54 | 23.54 | 23.54 | 23.54 | 23.54 |
| Inventories | 3,402.7 | 3,922.2 | 4,603.2 | 3,968.8 | 3,635.7 | 3,827.1 | 3,758.6 | 3,691.3 | 3,625.2 | 3,560.3 |
| Inventories, % | 15.32 | 20.11 | 22.71 | 19.21 | 17.75 | 19.02 | 19.02 | 19.02 | 19.02 | 19.02 |
| Accounts Payable | 2,409.0 | 2,128.2 | 2,237.4 | 2,179.4 | 2,080.5 | 2,153.1 | 2,114.5 | 2,076.7 | 2,039.5 | 2,003.0 |
| Accounts Payable, % | 10.85 | 10.91 | 11.04 | 10.55 | 10.15 | 10.7 | 10.7 | 10.7 | 10.7 | 10.7 |
| Capital Expenditure | -1,017.5 | -867.4 | -916.3 | -732.2 | -768.5 | -838.9 | -823.8 | -809.1 | -794.6 | -780.4 |
| Capital Expenditure, % | -4.58 | -4.45 | -4.52 | -3.54 | -3.75 | -4.17 | -4.17 | -4.17 | -4.17 | -4.17 |
| Tax Rate, % | 670.73 | 670.73 | 670.73 | 670.73 | 670.73 | 670.73 | 670.73 | 670.73 | 670.73 | 670.73 |
| EBITAT | 1,168.3 | 919.9 | -1,580.2 | -221.2 | -3,438.9 | 113.9 | 111.9 | 109.9 | 107.9 | 106.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4,366.0 | 1,066.6 | -1,060.6 | 912.3 | -2,239.5 | 660.4 | 937.4 | 920.7 | 904.2 | 888.0 |
| WACC, % | 6.69 | 6.94 | 6.86 | 6.8 | 5.7 | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 3,549.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 906 | |||||||||
| Terminal Value | 19,693 | |||||||||
| Present Terminal Value | 14,307 | |||||||||
| Enterprise Value | 17,857 | |||||||||
| Net Debt | 5,787 | |||||||||
| Equity Value | 12,070 | |||||||||
| Diluted Shares Outstanding, MM | 933 | |||||||||
| Equity Value Per Share | 12.93 |
What You Will Get
- Real PHG Financial Data: Pre-filled with Koninklijke Philips N.V.’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Koninklijke Philips N.V.’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive PHG Data: Pre-filled with Koninklijke Philips N.V.'s historical financials and future growth projections.
- Customizable Input Parameters: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures.
- Adaptive Valuation Model: Automatically refreshes Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- User-Centric Interface: Intuitive, organized, and tailored for both professionals and novices.
How It Works
- Download the Template: Gain immediate access to the Excel-based PHG DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Koninklijke Philips N.V.’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.
Why Choose This Calculator for Koninklijke Philips N.V. (PHG)?
- Accurate Data: Access real Koninklijke Philips financials for dependable valuation outcomes.
- Customizable: Tailor essential factors such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you from starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the healthcare technology sector.
- User-Friendly: An intuitive design and clear instructions ensure ease of use for everyone.
Who Should Use This Product?
- Healthcare Professionals: Leverage advanced analytics for evaluating Philips' medical technologies.
- Corporate Finance Teams: Assess valuation scenarios to inform strategic decisions related to Philips (PHG).
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Philips (PHG) stock.
- Students and Educators: Utilize real-world data to enhance learning in financial modeling and healthcare finance.
- Tech Enthusiasts: Gain insights into the valuation of innovative companies like Philips (PHG) in the healthcare sector.
What the Template Contains
- Preloaded PHG Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.